| Differences in metabolite profile between blood plasma and serum L Liu, J Aa, G Wang, B Yan, Y Zhang, X Wang, C Zhao, B Cao, J Shi, M Li, ... Analytical biochemistry 406 (2), 105-112, 2010 | 187 | 2010 |
| Dabigatran etexilate activation is affected by the CES1 genetic polymorphism G143E (rs71647871) and gender J Shi, X Wang, JH Nguyen, BE Bleske, Y Liang, L Liu, HJ Zhu Biochemical pharmacology 119, 76-84, 2016 | 125 | 2016 |
| GC/TOFMS analysis of metabolites in serum and urine reveals metabolic perturbation of TCA cycle in db/db mice involved in diabetic nephropathy M Li, X Wang, J Aa, W Qin, W Zha, Y Ge, L Liu, T Zheng, B Cao, J Shi, ... American Journal of Physiology-Renal Physiology 304 (11), F1317-F1324, 2013 | 113 | 2013 |
| Metabolomics and its application to the evaluation of the efficacy and toxicity of traditional Chinese herb medicines J Shi, B Cao, XW Wang, JY Aa, JA Duan, XX Zhu, GJ Wang, CX Liu Journal of Chromatography B 1026, 204-216, 2016 | 86 | 2016 |
| Metabolomic approach to evaluating adriamycin pharmacodynamics and resistance in breast cancer cells B Cao, M Li, W Zha, Q Zhao, R Gu, L Liu, J Shi, J Zhou, F Zhou, X Wu, ... Metabolomics 9, 960-973, 2013 | 86 | 2013 |
| Sensitive determination of 20 (S)-protopanaxadiol in rat plasma using HPLC–APCI-MS: Application of pharmacokinetic study in rats H Ren, J Sun, G Wang, A Ji-Ye, H Xie, W Zha, B Yan, F Sun, H Hao, S Gu, ... Journal of pharmaceutical and biomedical analysis 48 (5), 1476-1480, 2008 | 77 | 2008 |
| Label-free absolute protein quantification with data-independent acquisition B He, J Shi, X Wang, H Jiang, HJ Zhu Journal of proteomics 200, 51-59, 2019 | 76 | 2019 |
| Sacubitril is selectively activated by carboxylesterase 1 (CES1) in the liver and the activation is affected by CES1 genetic variation J Shi, X Wang, J Nguyen, AH Wu, BE Bleske, HJ Zhu Drug Metabolism and Disposition 44 (4), 554-559, 2016 | 76 | 2016 |
| Metabolic phenotype of rats exposed to heroin and potential markers of heroin abuse T Zheng, L Liu, J Aa, G Wang, B Cao, M Li, J Shi, X Wang, C Zhao, R Gu, ... Drug and alcohol dependence 127 (1-3), 177-186, 2013 | 72 | 2013 |
| Genome-wide pQTL analysis of protein expression regulatory networks in the human liver B He, J Shi, X Wang, H Jiang, HJ Zhu BMC biology 18, 1-16, 2020 | 71 | 2020 |
| Comparison of protein expression between human livers and the hepatic cell lines HepG2, Hep3B, and Huh7 using SWATH and MRM-HR proteomics: Focusing on drug-metabolizing enzymes J Shi, X Wang, L Lyu, H Jiang, HJ Zhu Drug metabolism and pharmacokinetics 33 (2), 133-140, 2018 | 66 | 2018 |
| The metabolic impact of methamphetamine on the systemic metabolism of rats and potential markers of methamphetamine abuse T Zheng, L Liu, J Shi, X Yu, W Xiao, R Sun, Y Zhou, J Aa, G Wang Molecular BioSystems 10 (7), 1968-1977, 2014 | 64 | 2014 |
| GC–TOFMS analysis of metabolites in adherent MDCK cells and a novel strategy for identifying intracellular metabolic markers for use as cell amount indicators in data normalization B Cao, J Aa, G Wang, X Wu, L Liu, M Li, J Shi, X Wang, C Zhao, T Zheng, ... Analytical and bioanalytical chemistry 400, 2983-2993, 2011 | 60 | 2011 |
| CES1 genetic variation affects the activation of angiotensin-converting enzyme inhibitors X Wang, G Wang, J Shi, J Aa, R Comas, Y Liang, HJ Zhu The pharmacogenomics journal 16 (3), 220-230, 2016 | 59 | 2016 |
| Comparative proteomics analysis of human liver microsomes and S9 fractions X Wang, B He, J Shi, Q Li, HJ Zhu Drug metabolism and disposition 48 (1), 31-40, 2020 | 56 | 2020 |
| Association of oseltamivir activation with gender and carboxylesterase 1 genetic polymorphisms J Shi, X Wang, RF Eyler, Y Liang, L Liu, BA Mueller, HJ Zhu Basic & clinical pharmacology & toxicology 119 (6), 555-561, 2016 | 50 | 2016 |
| Inhibition of P-glycoprotein by HIV protease inhibitors increases intracellular accumulation of berberine in murine and human macrophages W Zha, G Wang, W Xu, X Liu, Y Wang, BS Zha, J Shi, Q Zhao, PM Gerk, ... PloS one 8 (1), e54349, 2013 | 46 | 2013 |
| A pharmacometabonomic approach to predicting metabolic phenotypes and pharmacokinetic parameters of atorvastatin in healthy volunteers Q Huang, J Aa, H Jia, X Xin, C Tao, L Liu, B Zou, Q Song, J Shi, B Cao, ... Journal of proteome research 14 (9), 3970-3981, 2015 | 42 | 2015 |
| Gas chromatography time-of-flight mass spectrometry based metabolomic approach to evaluating toxicity of triptolide J Aa, F Shao, G Wang, Q Huang, W Zha, B Yan, T Zheng, L Liu, B Cao, ... Metabolomics 7, 217-225, 2011 | 42 | 2011 |
| Absolute quantitation of drug-metabolizing cytochrome P450 enzymes and accessory proteins in dog liver microsomes using label-free standard-free analysis reveals interbreed … SE Martinez, J Shi, HJ Zhu, TEP Jimenez, Z Zhu, MH Court Drug Metabolism and Disposition 47 (11), 1314-1324, 2019 | 39 | 2019 |
Xinwen WangNEOMEDAdresse e-mail validée de neomed.edu
